Catheter Precision Inc. (NYSE AMERICAN: VTAK) Stock Information | RedChip

Catheter Precision Inc. (NYSE AMERICAN: VTAK)


$0.4200
-0.0070 ( +2.97% ) 71.6K

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Market Data


Open


$0.4200

Previous close


$0.4270

Volume


71.6K

Market cap


$3.42M

Day range


$0.4070 - $0.4270

52 week range


$0.3110 - $8.4000

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 May 03, 2024
8-k 8K-related 16 Apr 03, 2024
8-k 8K-related 17 Apr 02, 2024
10-k Annual reports 124 Apr 01, 2024
8-k 8K-related 14 Jan 25, 2024
4 Insider transactions 1 Jan 24, 2024

Latest News


× Before browsing our site, please accept our cookies policy